Schmidt, C J <br/><br/>
Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  May 2008 
 - 681-90 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1521-0103 
<br/><br/><label>Standard No.: </label>10.1124/jpet.107.132910  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Behavior, Animal--drug effects<br/>Brain--drug effects<br/>Cyclic AMP--metabolism<br/>Cyclic GMP--metabolism<br/>Dopamine--metabolism<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Motor Activity--drug effects<br/>Phosphodiesterase Inhibitors--blood<br/>Phosphoric Diester Hydrolases--genetics<br/>Pyrazoles--pharmacology<br/>Quinolines--pharmacology<br/>Rats<br/>Rats, Inbred F344<br/>Recombinant Proteins--antagonists & inhibitors<br/>Reflex, Startle--drug effects<br/>Schizophrenia--drug therapy